selected scholarly activity
-
books
-
chapters
- A Primer on Biostatistics. 590-608. 2022
- Investigation of Acute Transfusion Reactions. 77-90. 2022
- Clinical Outcomes and Red Blood Cell Storage. 305-319. 2018
- Red cell, platelet, and white cell antigens. 509-546. 2013
- Febrile and Allergic Transfusion Reactions. 89-96. 2013
- Investigation of Acute Transfusion Reactions. 63-76. 2013
- Acquired hemolytic anemia. 157-172. 2011
- Acquired hemolytic anemia. 157-172. 2011
- Apheresis and whole blood derived platelets: Which product is best?. 121-136. 2010
- Febrile and Allergic Transfusion Reactions. 83-89. 2009
- Investigation of Acute Transfusion Reactions. 61-71. 2009
- Chapter 50 Febrile, Allergic, and Other Noninfectious Transfusion Reactions. 677-690. 2007
- Febrile, Allergic, and Other Noninfectious Transfusion Reactions. 677-690. 2007
- Febrile, Allergic, and Other Noninfectious Transfusion Reactions. 677-690. 2006
-
conferences
- Exploring the potential harm of varied blood storage on patients undergoing cardiovascular surgery. Vox Sanguinis. 947-954. 2023
- An evaluation of the clinical impacts of 7‐day platelets. Transfusion. 480-493. 2023
- Accuracy of International Classification of Diseases 10th Revision Codes for Transfusion-Related Immunomodulation Outcomes: Systematic Review and Meta-analysis. Transfusion. 155A-156A. 2021
- Platelet Transfusion Practice and Platelet Refractoriness: A Single Center Study for a Cohort of Pediatric Oncology Patients. Transfusion. 245A-246A. 2020
- Transfusion Reactions Following the Implementation of Seven Day Platelets. Transfusion. 256A-256A. 2020
- Identifying Patterns of Inappropriate Plasma Transfusion Practices Using a Novel Multicenter Electronic Data Audit: Over 80 Percent of Plasma Transfused Is Inappropriate. Blood. 3695-3695. 2019
- Perioperative Eltrombopag or Intravenous Immune Globulin for Patients with Immune Thrombocytopenia: A Multicenter Randomized Trial. Blood. 896-896. 2019
- Blood Loss From Laboratory Testing in the Intensive Care Unit and Transfusion: A Retrospective Study. Transfusion. 208A-208A. 2019
- The FIBRES Randomized Controlled Noninferiority Trial of Fibrinogen Concentrates Versus Cryoprecipitate in Cardiac Surgery: Subgroup and Safety Analysis. Transfusion. 8A-8A. 2019
- Sex‐mismatched red blood cell transfusions and mortality: A systematic review and meta‐analysis. Vox Sanguinis. 505-516. 2019
- Blood Loss Due to Laboratory Testing in Critical Care Patients: A Retrospective Cohort Study. Blood. 4885-4885. 2018
- Systematic reviews of guidelines and studies for single versus multiple unit transfusion strategies. Transfusion. 2841-2860. 2018
- Analysis of Red Blood Cell Storage Duration and in-Hospital Mortality Using Time Dependent Exposure: Is the Oldest Blood Bad?. Transfusion. 33A-33A. 2017
- Determining the Factors for Reassessment after Transfusion: A Canadian Survey. Transfusion. 170A-170A. 2017
- The Effect of Platelet Transfusion on Death in the Intensive Care Unit. Blood. 3850-3850. 2016
- Antibodies of Undetermined Significance in Solid-phase Technology, Exploring Incidence, Associated Patient Factors and Laboratory Impact. Transfusion. 132A-133A. 2016
- Audit of Provincial IVIG Request Forms and Efficacy Documentation in Four Tertiary Care Centres in Canada. Transfusion. 177A-178A. 2016
- Developing a Data-driven Research Program: An Integrated Database Network Tool Driving Education and Research Forward. Transfusion. 237A-237A. 2016
- Group O Utilization Patterns: The GROUP Study. Transfusion. 14A-15A. 2016
- How Many AB Plasma Units Were Infused? The HABSWIN Study. Transfusion. 169A-169A. 2016
- Informing Fresh Versus Old Red Cell Management (INFORM) Trial: A Large International Pragmatic Randomized Trial. Transfusion. 5A-5A. 2016
- Red Cell Antigen Genotyping Compared to Serological Phenotyping in Sickle Cell Disease Patients in Canada: Potential for Reducing Alloimmunization. Transfusion. 153A-153A. 2016
- Transfusion Premedication Practices in Pediatrics: Results of a Canadian Survey. Transfusion. 19A-20A. 2016
- A Qualitative Research Study to Understand Post-Transfusion Well-Being in Patients with Myelodysplastic Syndromes. Blood. 4446-4446. 2015
- Assessing Disease Stability of Patients with Myelodysplastic Syndrome for an Age of Blood Randomized Controlled Trial: A Chart Review. Blood. 5252-5252. 2015
- Management of Osteonecrosis By Adult and Pediatric Sickle Cell Providers. Blood. 2015
- Non-Specific Hemostatic Agents (PCC, aPCC, rVIIa) for Reversal of Direct Oral Anticoagulant Effect in Patients with Major Bleeding Complications: A Retrospective Review. Blood. 1137-1137. 2015
- Red Cell Antigen Genotyping Compared to Standard Serological Phenotyping in Sickle Cell Disease Patients in Canada: Potential for Reducing Alloimmunization. Blood. 2015
- Clinical Efficacy and Safety of Platelets in Additive Solution Treated With Two Commercial Pathogen Reduction Technologies. Transfusion. 3A-4A. 2015
- Exploratory Analysis of a Blood Processing Method and In-hospital Mortality. Transfusion. 23A-23A. 2015
- Exploratory Analysis of the Association Between Donor Sex and Inhospital Mortality in Transfusion Recipients. Transfusion. 23A-24A. 2015
- Group O Red Blood Cells: Where is Universal donor blood Being Used?. Transfusion. 153A-154A. 2015
- Group O and RhD=Negative Utilization Patterns and Associated Hospital Policies: A Multicenter, International Study. Transfusion. 154A-154A. 2015
- Quantification of Cell-free DNA in Red Blood Cell Concentrates Produced via Buffy Coat or Whole Blood-Filtered Methods. Transfusion. 9A-9A. 2015
- Red Blood Cell Transfusion Antigen Matching Influence on Gestational Outcomes (AMIGO) Study. Transfusion. 25A-25A. 2015
- Interventions to reduce blood loss from laboratory testing in critically ill patients and impact on transfusion: a systematic review. Journal of Thrombosis and Haemostasis. 974-975. 2015
- Utilization of Universal Group O Blood By Non Group O Recipients. Blood. 5103-5103. 2014
- A Retrospective Review of Platelet Refractoriness in a Cohort of Pediatric Oncology Patients. Transfusion. 135A-135A. 2014
- Donath-Landsteiner Testing: A Retrospective Review of Testing During Seven Years at a Large Academic Health Center and Results of a National Survey. Transfusion. 225A-225A. 2014
- Exposure To ABO Compatible But Non-Group Identical Blood and In-Hospital Mortality. Blood. 3651-3651. 2013
- Perioperative Management Of Patients On Dabigatran – a Prospective Cohort Study. Blood. 3637-3637. 2013
- Transfusion Related Alloimmunization In Children: Epidemiology and Effects Of Chemotherapy (TRACE-EC Study). Blood. 1161-1161. 2013
- Transfusion-Related Iron Overload: A Covert Risk Of Supportive Cancer Care. Blood. 3656-3656. 2013
- BENCHMARKING: APPLICATIONS TO TRANSFUSION MEDICINE. Vox Sanguinis. 9-9. 2013
- CLINICAL TRIALS ON PLATELET TRANSFUSION: SUCCESSES AND FAILURES. Vox Sanguinis. 41-41. 2013
- Use of Intravenous Immune Globulin in Patients with Immune Thrombocytopenia Before and After Romiplostim: Real-World Experience. Blood. 4641-4641. 2012
- An Epidemiological Cohort Study of Blood Transfusion Practices Among a Population of Pediatric Oncology Patients. Transfusion. 114A-115A. 2012
- Mortality, Blood Storage Duration, and Method of Red Cell Production: An Exploratory Analysis. Transfusion. 51A-52A. 2012
- A Pilot Study Evaluating the Effects of Intravenous Immunoglobulin (IVIG) Administration on Serological Test Results and Adverse Events. Transfusion. 154A-154A. 2011
- Can We Do a 25,000 Patient Pragmatic Study to Address the Age of Blood and Mortality Controversy? A Pilot to Determine Feasibility. Transfusion. 193A-193A. 2011
- A prospective cohort study of bleeding symptoms among persons referred to hematologists who are diagnosed with or excluded of having bleeding disorders. Journal of Thrombosis and Haemostasis. 687-688. 2011
- Bleeding risks associated with inherited platelet disorders: results from a prospective cohort study. Journal of Thrombosis and Haemostasis. 687-687. 2011
- Optimal timing and dosing of platelet transfusions. ISBT Science Series. 88-94. 2010
- Diagnostic Utility of Platelet Secretion Testing by ATP Release Assays: Results From a Prospective Study of Individuals Referred for Bleeding Disorder Assessments.. Blood. 537-538. 2009
- Duration of Red Cell Storage and In-hospital Mortality in Patients with Cardiovascular Disease. Transfusion. 24A-25A. 2009
- The Development of a Bleeding Severity Measurement Scale (BSMS): A New Measurement Tool. Transfusion. 165A-165A. 2009
- Evaluation of a method to assess platelet function in individuals with thrombocytopenia. Haemophilia. 626-626. 2009
- The value of evidence‐based medicine. ISBT Science Series. 1-7. 2008
- 521: Postpartum FMH testing to prevent Rh alloimmunization: How often does it change management?. American Journal of Obstetrics and Gynecology. S152-S152. 2007
- A systematic review and meta-analysis of platelets prepared from apheresis versus whole blood. Transfusion. 190A-190A. 2007
- Do transfusion committees meet their objectives?. Transfusion. 264A-264A. 2007
- Controversy concerning platelet dose. ISBT Science Series. 220-225. 2007
- A Pre/Post observational study of the impact on transfusion reactions by the implementation of the 'Buffy Coat' method. Transfusion. 85A-86A. 2006
- A management tool to track platelet inventory patterns and wastage in 26 hospitals. Transfusion. 229A-229A. 2006
- Development of a conceptual model to describe the experience of permanent donor deferral. Transfusion. 203A-203A. 2006
- A multicenter, randomized, controlled clinical pilot trial of the feasibility of an intensive RBC transfusion policy for patients with acute leukemia treated with induction chemotherapy or stem cell transplant.. Blood. 126B-126B. 2005
- A revisit of the criteria to define remission in patients with idiopathic thrombocytopenia undergoing splenectomy.. Blood. 846A-846A. 2005
- Pitfalls in interpreting platelet function tests in thrombocytopenic patients referred by a hematologist for diagnostic testing: Results from a single center prospective study.. Blood. 75B-75B. 2005
- Insights into the risk of bleeding in thrombocytopenic patients with acute leukemia. Transfusion. 12A-13A. 2005
- Patient self-assessment of bleeding symptoms. Transfusion. 145A-145A. 2005
- The cost of "utilization" and "wastage" of red blood cells and platelets in a Canadian regional laboratory program. Transfusion. 202A-202A. 2005
- Analysis of dosing variability of IVIG in community and teaching hospitals. Blood. 745A-745A. 2004
- Platelet Transfusions in a Medical- Surgical Intensive Care Unit.. Blood. 3637-3637. 2004
- The Use of Aprotinin to Reduce Transfusion Requirements in Children Undergoing Cardiac Surgery: A Meta-Analysis.. Blood. 2718-2718. 2004
- Triple Immunosuppressive Therapy in Patients with Chronic Resistant Immune Thrombocytopenic Purpura; a Case Series of 11 Patients.. Blood. 2059-2059. 2004
- 270 A Randomized Controlled Trial of Low vs High Hemoglobin Thresholds for Transfusion in Extremely Low-Birth-Weight Infants. Pediatric Research. 510-510. 2004
- A randomized crossover trial comparing in-vivo platelet recovery and survival of leukoreduced apheresis and whole blood derived platelets. Transfusion. 1A-1A. 2004
- Identifying the optimal red cell transfusion threshold for extremely low birth weight infants: The premature in need of transfusion (PINT) study. Transfusion. 1A-1A. 2004
- A randomized trial in hemophilic patients comparing handheld computers with paper diaries for submission of coagulation factor concentrate infusion data.. Blood. 107B-107B. 2003
- Bleeding symptomatology associated with inheritance of the Quebec platelet disorder.. Blood. 785A-785A. 2003
- Predictors of infection and bleeding in patients with chemotherapy induced thrombocytopenia. Blood. 556A-557A. 2003
- Auditing of hospital armband identification practices in four acute care hospitals. Transfusion. 171A-171A. 2003
- Comparison of methods for the analysis of bleeding outcomes in platelet transfusion studies. Transfusion. 31A-31A. 2003
- Evaluation of a bacteria detection system using whole blood derived platelets stored individually and as a pool for up to 7 days. Transfusion. 46A-47A. 2003
- Severe hypotension following transfusion of pre-storage leukoreduced red blood cells and acute normovolemic hemodilution whole blood. Transfusion. 112A-112A. 2003
- Success in achieving a targeted platelet dose: What dose are we actually giving?. Transfusion. 30A-31A. 2003
- A prospective study of clinical laboratory findings in patients referred by a hematologist for investigation of a suspected platelet disorder.. Blood. 690A-690A. 2002
- Evaluation of a directed donor transfusion program in the Neonatal Intensive Care Unit: Does directed donation reduce allogeneic exposures to neonates?. Blood. 288A-288A. 2002
- A survey of blood collection activities in hospital transfusion services.. Transfusion. 141S-141S. 2002
- Evaluation of whole blood derived platelets stored as a pool for 7 days.. Transfusion. 11S-11S. 2002
- Vein to vein tracking system for factor concentrates.. Transfusion. 136S-136S. 2002
- Effect of splenectomy in patients with chronic idiopathic thrombocytopenic purpura.. Blood. 524A-524A. 2001
- Evaluation of whole blood derived platelets stored as a pool.. Blood. 449A-449A. 2001
- A feasibility pilot study using medical records and laboratory information systems to address blood utilization issues. Transfusion. 51S-51S. 2001
- A study to determine the accuracy of transfusion coding by hospital medical records departments. Transfusion. 131S-132S. 2001
- Detection of mixed field reactions in ABO groupings and Rh typings. Transfusion. 107S-107S. 2001
- Pilot study to determine baseline transfusion medicine knowledge of nurses working on a Hematology/Oncology Service. Transfusion. 27S-27S. 2001
- Team development project in an academic transfusion medicine service. Transfusion. 129S-130S. 2001
- Comparison of post transfusion platelet response following random donor and apheresis platelets.. Blood. 62A-62A. 2000
- Comparison of post transfusion platelet response following random donor and apheresis platelets. Transfusion. 45S-45S. 2000
- Evaluation of clot formation in AS-3 red cells diluted with Ringer's Lactate. Transfusion. 132S-132S. 2000
- A randomized trial comparing plasma removal to two types of pre-storage leukoreduction to prevent reactions to platelets.. Blood. 376A-376A. 1999
- Evaluation of clot formation in AS-3 red cells diluted with Ringer's lactate.. Blood. 461A-461A. 1999
- A randomized trial comparing plasma removal to two types of pre-storage leukoreduction to prevent reactions to platelets. Transfusion. 96S-97S. 1999
- Acute reactions to platelets: A new classification and interobserver reliability studies.. Transfusion. 40S-40S. 1998
- Face validity of a new classification for platelet reactions.. Transfusion. 43S-43S. 1998
- Comparison of gel and tube techniques for direct antiglobulin tests. Transfusion. S108-S108. 1997
- Clinical relevance of cytokine levels in blood products: Evidence to correlate with morbidity. CYTOKINES AND GROWTH FACTORS IN BLOOD TRANSFUSION. 105-122. 1997
- Future potential of cytokines and growth factors in transfusion medicine - Discussion. CYTOKINES AND GROWTH FACTORS IN BLOOD TRANSFUSION. 189-198. 1997
- Role and application of cytokines and growth factors in clinical medicine - Discussion. Developments in Hematology and Immunology. 165-173. 1997
- A comparison of two interventions to prevent platelet reactions.. Transfusion. S185-S185. 1996
- The effect of blood product preparation on cytokine levels.. Transfusion. S3-S3. 1996
- Acute transfusion reactions in pediatric patients.. Blood. 3407-3407. 1995
- Evidence for in vivo thrombin generation following the transfusion of blood from a post-operative drainage device.. Blood. 2159-2159. 1995
- EFFICACY OF ANTI-D TO IMPROVE PLATELET TRANSFUSION RESPONSE - A RANDOMIZED TRIAL. Blood. A403-A403. 1993
- PLATELET REACTIONS CAUSED PRIMARILY BY PLASMA SUPERNATANT. Transfusion. S62-S62. 1993
- RISK OF ALLOIMMUNIZATION AND TRANSFUSION IN HIGH-RISK OBSTETRICAL PATIENTS. Transfusion. S61-S61. 1993
- BLOOD PRODUCT AGE PREDICTS TRANSFUSION REACTIONS (TR). Transfusion. S59-S59. 1992
- Impact of a randomized trial on transfusion practice in orthopedic surgery. Contemporary Clinical Trials. 431-431. 1992
- HYPERGAMMAGLOBULINEMIA CAN BE ASSOCIATED WITH A POSITIVE DIRECT ANTIGLOBULIN-TEST, A NON-REACTIVE ELUATE, AND NO EVIDENCE OF HEMOLYSIS. Transfusion. 451-451. 1985
- ABSENCE OF HEMOLYSIS OF T-ACTIVATED RED-CELLS FOLLOWING INFUSION OF BLOOD PRODUCTS. Transfusion. 384-384. 1978
- ABSENCE OF HEMOLYSIS OF T-ACTIVATED RED-CELLS FOLLOWING INFUSION OF BLOOD PRODUCTS. Transfusion. 686-686. 1977
-
journal articles
- Donor clinical characteristics and impacts on transfusion recipient outcomes.. Transfusion and Apheresis Science. 63:104012. 2024
- Meta-analysis of efficacy and safety of pathogen-reduced platelet components: Request for clarification.. Vox Sanguinis. 2024
- Healthcare provider's perceptions of bleeding in patients with acute leukaemia undergoing induction chemotherapy: A qualitative study. Transfusion Medicine. 34:268-277. 2024
- Reducing blood product wastage through the inter‐hospital redistribution of near‐outdate inventory. Transfusion. 64:1207-1216. 2024
- A randomized control trial to compare mortality in recipients of leucoreduced and non-leucoreduced whole blood transfusion in patients with cancer in Uganda. BMC Cancer. 24:677. 2024
-
Quality of life and
cost‐effectiveness of convalescent plasma compared to standard care for hospitalizedCOVID ‐19 patients in theCONCOR ‐1 trial. Transfusion. 64:606-614. 2024 - Accuracy of venous thromboembolism ICD-10 codes: A systematic review and meta-analysis. Thrombosis Update. 14:100154-100154. 2024
- Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Combined results from two randomized controlled feasibility studies. American Journal of Hematology. 99:473-476. 2024
-
Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Results of a pilot randomized trial
RBC‐ENHANCE . Transfusion. 64:223-235. 2024 - Demand forecasting for platelet usage: From univariate time series to multivariable models. PLoS ONE. 19:e0297391-e0297391. 2024
- An unsupervised learning approach to identify immunoglobulin utilization patterns using electronic health records. Transfusion. 63:2234-2247. 2023
- Frequency of red blood cell allo-immunization in patients undergoing blood transfusion at the Uganda Cancer Institute. African Health Sciences. 23:362-370. 2023
- Data-driven fair resource allocation for novel emerging epidemics: a COVID-19 Convalescent Plasma case study. INFOR: Information Systems and Operational Research. 61:559-588. 2023
- P‐TS‐10 | An Unsupervised Learning Approach to Identify Immunoglobulin Utilization Patterns Using Electronic Health Records. Transfusion. 63:261A-262A. 2023
- P‐TS‐29 | Effect of Donor and Recipient Characteristics on Hemoglobin Increments in Intensive Care Unit Patients Receiving Red Blood Cell Transfusion. Transfusion. 63:274A-274A. 2023
- Immunoglobulin utilization in Canada: a comparative analysis of provincial guidelines and a scoping review of the literature. Allergy, Asthma and Clinical Immunology. 19:85. 2023
- A retrospective analysis of haemolytic reactions to intravenous immunoglobulin using data from the Transfusion‐Transmitted Injuries Surveillance System (Ontario). Vox Sanguinis. 118:753-762. 2023
- Laboratory and demographic predictors of functional assay positive status in suspected heparin-induced thrombocytopenia: A multicenter retrospective cohort study. Thrombosis Research. 229:198-208. 2023
-
KEL1 negative red cell transfusions for females of current or futurechild‐bearing potential: A clinical impact and feasibility study. Transfusion. 63:59-68. 2023 - A positive blood culture is associated with a lower haemoglobin increment in hospitalized patients after red blood cell transfusion. Vox Sanguinis. 118:33-40. 2023
-
A
data‐informed system to manage scarce blood product allocation in a randomized controlled trial of convalescent plasma. Transfusion. 62:2525-2538. 2022 - A cross‐sectional study of haemolytic disease of the newborn in Uganda. Vox Sanguinis. 117:1398-1404. 2022
- Development and internal validation of a clinical prediction model for the diagnosis of immune thrombocytopenia. Journal of Thrombosis and Haemostasis. 20:2988-2997. 2022
- Accuracy of International Classification of Diseases, 10th Revision Codes for Identifying Sepsis: A Systematic Review and Meta-Analysis. Critical Care Explorations. 4:e0788-e0788. 2022
- A data‐driven approach to determine daily platelet order quantities at hospitals. Transfusion. 62:2048-2056. 2022
- Plasma transfusion practices: A multicentre electronic audit. Vox Sanguinis. 117:1211-1219. 2022
- Impact of cardiopulmonary bypass duration on efficacy of fibrinogen replacement with cryoprecipitate compared with fibrinogen concentrate: a post hoc analysis of the Fibrinogen Replenishment in Surgery (FIBRES) randomised controlled trial. British Journal of Anaesthesia. 129:294-307. 2022
- Genome-wide association study of platelet factor 4/heparin antibodies in heparin-induced thrombocytopenia. Blood Advances. 6:4137-4146. 2022
- ABO O blood group as a risk factor for platelet reactivity in heparin-induced thrombocytopenia. Blood. 140:274-284. 2022
- Database‐driven research and big data analytic approaches in transfusion medicine. Transfusion. 62:1427-1434. 2022
- Reflections of Dr. Morris Blajchman (1940-2022). Transfusion Medicine Reviews. 36:115-116. 2022
- Use of Irradiated Red Blood Cell Transfusions in Newborns to Improve Intracerebral Saturation. JAMA Pediatrics. 176:e220149-e220149. 2022
- Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia. Blood Advances. 6:785-792. 2022
- Author Correction: Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial. Nature Medicine. 28:212-212. 2022
- From demand forecasting to inventory ordering decisions for red blood cells through integrating machine learning, statistical modeling, and inventory optimization. Transfusion. 62:87-99. 2022
- Mortality and its associated factors in transfused patients at a tertiary hospital in Uganda. PLoS ONE. 17:e0275126-e0275126. 2022
- Prolonged Blood Storage and Risk of Posttransfusion Acute Kidney Injury. Anesthesiology. 136:138-147. 2022
- Reply to: Concerns about estimating relative risk of death associated with convalescent plasma for COVID-19. Nature Medicine. 28:53-58. 2022
- Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial. Nature Medicine. 27:2012-2024. 2021
-
Necrotizing enterocolitis and mortality after transfusion of
ABO non‐identical blood. Transfusion. 61:3094-3103. 2021 - Platelet variability index: a measure of platelet count fluctuations in patients with immune thrombocytopenia. Blood Advances. 5:4256-4264. 2021
- A decision integration strategy for short-term demand forecasting and ordering for red blood cell components. Operations Research for Health Care. 29:100290-100290. 2021
- Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): study protocol for an international, multicentre, randomized, open-label trial. Trials. 22:323. 2021
- Exploring the components of bleeding outcomes in transfusion trials for patients with hematologic malignancy. Transfusion. 61:286-293. 2021
- Platelet transfusion practice and platelet refractoriness for a cohort of pediatric oncology patients: A single‐center study. Pediatric Blood and Cancer. 67:e28734. 2020
- Genome-Wide Association Study Identifies Variation in ABO As Risk Factor for Platelet Reactivity in Heparin-Induced Thrombocytopenia. Blood. 136:38-39. 2020
- Devices to Reduce the Volume of Blood Taken for Laboratory Testing in ICU Patients: A Systematic Review. Journal of Intensive Care Medicine. 35:1074-1079. 2020
- Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trial. The Lancet Haematology. 7:e640-e648. 2020
- Utilising red cell antigen genotyping and serological phenotyping in sickle cell disease patients to risk‐stratify patients for alloimmunisation risk. Transfusion Medicine. 30:263-274. 2020
- Revisiting study design and methodology for pathogen reduced platelet transfusions: a round table discussion. Transfusion. 60:1604-1611. 2020
- A crosswalk tabular review on methods and outcomes from randomized clinical trials using pathogen reduced platelets. Transfusion. 60:1267-1277. 2020
- Blood loss from laboratory testing, anemia, and red blood cell transfusion in the intensive care unit: a retrospective study. Transfusion. 60:256-261. 2020
- Effect of Fibrinogen Concentrate vs Cryoprecipitate on Blood Component Transfusion After Cardiac Surgery. Journal of the American Medical Association (JAMA). 322:1966-1966. 2019
- Not all red cell concentrate units are equivalent: international survey of processing and in vitro quality data. Vox Sanguinis. 114:783-794. 2019
- Critical developments of 2018: A review of the literature from selected topics in transfusion. A committee report from the AABB's Clinical Transfusion Medicine Committee. Transfusion. 59:2733-2748. 2019
- The association between platelet transfusions and mortality in patients with critical illness. Transfusion. 59:1962-1970. 2019
- Peri-Operative Eltrombopag or Immune Globulin for Patients with Immune Thrombocytopaenia (The Bridging ITP Trial): Methods and Rationale. Thrombosis and Haemostasis. 119:500-507. 2019
- The association between blood donor sex and age and transfusion recipient mortality: an exploratory analysis. Transfusion. 59:482-491. 2019
- Systematic review of rituximab for autoimmune diseases: a potential alternative to intravenous immune globulin. Transfusion. 58:2729-2735. 2018
- Top 10 mistakes made in research. Transfusion. 58:2478-2482. 2018
- Neutropenia and monocytopenia in recurrent anaphylactoid reactions after red blood cell transfusions in a woman with immunoglobulin A (IgA) deficiency and anti‐IgA. Transfusion. 58:2320-2325. 2018
- Hemostatic efficacy of pathogen-inactivated vs untreated platelets: a randomized controlled trial. Blood. 132:223-231. 2018
- Critical developments of 2017: a review of the literature from selected topics in transfusion. A committee report from the AABB Clinical Transfusion Medicine Committee. Transfusion. 58:1065-1075. 2018
- Impact of organizational interventions on reducing inappropriate intravenous immunoglobulin (IVIG) usage: A systematic review and meta-analysis. Transfusion and Apheresis Science. 57:215-221. 2018
- Protocol for a phase III, non-inferiority, randomised comparison of a new fibrinogen concentrate versus cryoprecipitate for treating acquired hypofibrinogenaemia in bleeding cardiac surgical patients: the FIBRES trial. BMJ Open. 8:e020741-e020741. 2018
- A brief survey of clinicians’ perceptions of parent preferences for involvement in obstetrical and perinatal management decisions in haemophilia. Haemophilia. 24:e80-e83. 2018
- An international investigation into AB plasma administration in hospitals: how many AB plasma units were infused? The HABSWIN study. Transfusion. 58:151-157. 2018
- Exploring donor and product factors and their impact on red cell post-transfusion outcomes. Transfusion Medicine Reviews. 32:28-35. 2018
- Red blood cell storage and in-hospital mortality: a secondary analysis of the INFORM randomised controlled trial. The Lancet Haematology. 4:e544-e552. 2017
- An international investigation into O red blood cell unit administration in hospitals: the GRoup O Utilization Patterns (GROUP) study. Transfusion. 57:2329-2337. 2017
- From cytokines to pragmatic designs: changing paradigms. Transfusion. 57:2298-2306. 2017
-
Group O
RBC s: where is universal donor blood being used. Vox Sanguinis. 112:336-342. 2017 -
Audit of provincial
IVIG Request Forms and efficacy documentation in four Ontario tertiary care centres. Transfusion Medicine. 27:122-131. 2017 - Mortality outcomes in patients transfused with fresher versus older red blood cells: a meta‐analysis. Vox Sanguinis. 112:268-278. 2017
- Short-Term versus Long-Term Blood Storage. New England Journal of Medicine. 376:1091-1094. 2017
- Blood Group Antigen Matching Influence on Gestational Outcomes (AMIGO) study. Transfusion. 57:525-532. 2017
- Warm‐reactive (immunoglobulin G) autoantibodies and laboratory testing best practices: review of the literature and survey of current practice. Transfusion. 57:463-477. 2017
- Paroxysmal cold hemoglobinuria: a difficult diagnosis in adult patients. Transfusion. 57:137-143. 2017
- Effect of Short-Term vs. Long-Term Blood Storage on Mortality after Transfusion. New England Journal of Medicine. 375:1937-1945. 2016
- Clinical Practice Guidelines From the AABB. Journal of the American Medical Association (JAMA). 316:2025-2025. 2016
- Red blood cell transfusion: 2016 clinical practice guidelines from AABB. Transfusion. 56:2627-2630. 2016
- Transfusion‐related alloimmunization in children: epidemiology and effects of chemotherapy. Vox Sanguinis. 111:299-307. 2016
- Quantification of Cell-Free DNA in Red Blood Cell Units in Different Whole Blood Processing Methods. Journal of Blood Transfusion. 2016:1-5. 2016
- Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal A systematic review and meta-analysis. Thrombosis and Haemostasis. 116:879-890. 2016
- Transfusion premedication practices among pediatric health care practitioners in Canada: results of a national survey. Transfusion. 56:2296-2302. 2016
- An evaluation of overall effectiveness and treatment satisfaction with intravenous immunoglobulin among patients with immune thrombocytopenia. Transfusion. 56:1739-1744. 2016
- Understanding intravenous iron ordering practices for inpatients and outpatients at a large academic institution. Transfusion Medicine Reviews. 30:147-147. 2016
- Understanding stakeholder important outcomes and perceptions of equity, acceptability and feasibility of a care model for haemophilia management in the US: a qualitative study. Haemophilia. 22:23-30. 2016
- AABB Committee Report: reducing transfusion‐transmitted cytomegalovirus infections. Transfusion. 56:1581-1587. 2016
- Red blood cell processing methods and in-hospital mortality: a transfusion registry cohort study. The Lancet Haematology. 3:e246-e254. 2016
- Red blood cell processing methods and in-hospital mortality: a transfusion registry cohort study. The Lancet Haematology. 3:E246-E254. 2016
- Reducing the age of transfused red blood cells in hospitals: ordering and allocation policies. Vox Sanguinis. 110:385-392. 2016
- CONSORT and clinical trial reporting: room for improvement. Transfusion. 56:781-783. 2016
- Public Perceptions of Pathogen Reduction Technology in the Canadian Donor Blood Supply. ISBT Science Series. 11:14-23. 2016
-
Exposure to
ABO ‐nonidentical blood associated with increased in‐hospital mortality in patients with groupA blood. Transfusion. 56:550-557. 2016 - Transfusion of fresher vs older red blood cells in hospitalized patients: a systematic review and meta-analysis. Blood. 127:400-410. 2016
- A study protocol for a randomised controlled trial evaluating clinical effects of platelet transfusion products: the Pathogen Reduction Evaluation and Predictive Analytical Rating Score (PREPAReS) trial. BMJ Open. 6:e010156-e010156. 2016
- Effect of a thrombopoietin receptor agonist on use of intravenous immune globulin in patients with immune thrombocytopenia. Transfusion. 56:73-79. 2016
- Platelet Transfusion Practices in the ICU: Data From a Large Transfusion Registry. Chest. 150:516-523. 2016
- Rationale and Design of the Informing Fresh versus Old Red Cell Management (INFORM) Trial: An International Pragmatic Randomized Trial. Transfusion Medicine Reviews. 30:25-29. 2016
- 2015 proceedings of the National Heart, Lung, and Blood Institute's State of the Science in Transfusion Medicine symposium. Transfusion. 55:2282-2290. 2015
- Combination of 4Ts score and PF4/H-PaGIA for diagnosis and management of heparin-induced thrombocytopenia: prospective cohort study. Blood. 126:597-603. 2015
- Perioperative Management of Dabigatran. Circulation. 132:167-173. 2015
- A benchmarking program to reduce red blood cell outdating: implementation, evaluation, and a conceptual framework. Transfusion. 55:1621-1627. 2015
- Intravenous Immunoglobulin (IVIg) Utilization in Immune Thrombocytopenia (ITP): A Multi-Center, Retrospective Review. Drugs - Real World Outcomes. 2:35-42. 2015
- Treatment decision‐making among Canadian youth with severe haemophilia: a qualitative approach. Haemophilia. 21:180-189. 2015
- Exploratory studies on the age of transfused blood and in‐hospital mortality in patients with cardiovascular diagnoses. Transfusion. 55:364-372. 2015
- Rituximab plus standard of care for treatment of primary immune thrombocytopenia: a systematic review and meta-analysis. The Lancet Haematology. 2:e75-e81. 2015
- Understanding why patients with immune thrombocytopenia are deeply divided on splenectomy. Health Expectations. 17:809-817. 2014
- Prophylactic platelet transfusions. Current Opinion in Hematology. 21:521-527. 2014
- An epidemiologic cohort study reviewing the practice of blood product transfusions among a population of pediatric oncology patients. Transfusion. 54:2736-2744. 2014
- Risks, benefits and the role of stakeholders in pathogen reduction technology. Health, Risk & Society. 16:547-564. 2014
- A 13-Question Approach to Resolving Serological Discrepancies in the Transfusion Medicine Laboratory. Laboratory Medicine. 45:193-206. 2014
-
First analysis of 10‐year trends in national factor concentrates usage in haemophilia: data from
CHARMS , the Canadian Hemophilia Assessment and Resource Management System. Haemophilia. 20:e251-e259. 2014 - Implementation and public acceptability: lessons from food irradiation and how they might apply to pathogen reduction in blood products. Vox Sanguinis. 107:50-59. 2014
- Counting platelets at transfusion threshold levels: impact on the decision to transfuse. A BEST Collaborative ‐ UK NEQAS(H) International Exercise. Vox Sanguinis. 106:330-336. 2014
-
What should men living with haemophilia need to know? The perspectives of
C anadian men with haemophilia. Haemophilia. 20:219-225. 2014 - Platelet transfusions for critically ill patients with thrombocytopenia. Blood. 123:1146-1151. 2014
- External validation of a risk assessment model for venous thromboembolism in the hospitalised acutely-ill medical patient (VTE-VALOURR). Thrombosis and Haemostasis. 112:692-699. 2014
- Exploring resource allocation and alternate clinic accessibility landscapes for improved blood donor turnout. Applied Geography. 45:89-97. 2013
- The Use Of Platelet Transfusions In The Intensive Care Unit and Impact On Platelet Count: A 30,000 Patient Registry Study. Blood. 122:1154-1154. 2013
- The effect of rituximab on vaccine responses in patients with immune thrombocytopenia. Blood. 122:1946-1953. 2013
- A survey of patients with haemophilia to understand how they track product used at home. Haemophilia. 19:e289-e295. 2013
- Clinical trials evaluating pathogen‐reduced platelet products: methodologic issues and recommendations. Transfusion. 53:1843-1855. 2013
- The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions. Transfusion. 53:1531-1543. 2013
- What should men living with severe haemophilia need to know? The perspectives of Canadian haemophilia health care providers. Haemophilia. 19:503-510. 2013
- A reporting guideline for clinical platelet transfusion studies from the BEST Collaborative. Transfusion. 53:1328-1334. 2013
- Pooled Platelet Concentrates or Apheresis Platelets?. New England Journal of Medicine. 368:1848-1849. 2013
- Donor Exposures in Recipients of Pooled Platelet Concentrates. New England Journal of Medicine. 368:487-489. 2013
- The authors reply. New England Journal of Medicine. 368:1849. 2013
- Ten-Year Canadian National Prospective Data On Utilization of Anti-Hemophilic Concentrates: Indications and Trends. Blood. 120:1186-1186. 2012
- A new tool to assess bleeding severity in patients with chemotherapy‐induced thrombocytopenia (CME). Transfusion. 52:2466-2474. 2012
-
Continuing Medical Education Program in
T ransfusion. Transfusion. 52:2465-2465. 2012 - Benchmarking: Applications to Transfusion Medicine. Transfusion Medicine Reviews. 26:321-332. 2012
- Challenges and opportunities to prevent transfusion errors: a Qualitative Evaluation for Safer Transfusion (QUEST). Transfusion. 52:1687-1695. 2012
- The Canadian Transfusion Surveillance System: What is it and how can the data be used?. Transfusion and Apheresis Science. 46:329-335. 2012
- The effect of blood storage duration on in‐hospital mortality: a randomized controlled pilot feasibility trial. Transfusion. 52:1203-1212. 2012
- The role of comparative effectiveness research in transfusion medicine clinical trials: proceedings of a National Heart, Lung, and Blood Institute workshop. Transfusion. 52:1363-1378. 2012
- Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation. Clinical Respiratory Journal. 5:CD004269. 2012
- Individual and contextual determinants of blood donation frequency with a focus on clinic accessibility: A case study of Toronto, Canada. Health & Place. 18:424-433. 2012
- A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia. Blood. 119:1356-1362. 2012
- Forecasting Ontario's blood supply and demand. Transfusion. 52:366-374. 2012
- Do expert assessments converge? An exploratory case study of evaluating and managing a blood supply risk. BMC International Health and Human Rights. 11:666. 2011
- Adjudicating bleeding events in a platelet dose study: impact on outcome results and challenges. Transfusion. 51:2304-2310. 2011
- Diagnostic Usefulness of a Lumi-Aggregometer Adenosine Triphosphate Release Assay for the Assessment of Platelet Function Disorders. American Journal of Clinical Pathology. 136:350-358. 2011
- ‘Someone else’s blood’: directed blood donation for neonatal transfusion and parental perceptions of risk. Journal of Risk Research. 14:837-845. 2011
- Evaluation of noninvasive methods for the estimation of haemoglobin content in red blood cell concentrates. Transfusion Medicine. 21:145-149. 2011
- Time to rethink clinically important outcomes in platelet transfusion trials. Transfusion. 51:430-434. 2011
- Composite outcomes in clinical trials: what are they and when should they be used?. Transfusion. 51:11-13. 2011
- Misleading hepatitis B test results due to intravenous immunoglobulin administration: implications for a clinical trial of rituximab in immune thrombocytopenia. Transfusion. 50:2577-2581. 2010
- Understanding Treatment Preferences In Patients with Primary Immune Thrombocytopenia Contemplating Splenectomy: A Qualitative Study. Blood. 116:392-392. 2010
- A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology. Transfusion. 50:2362-2375. 2010
- A systematic assessment of the quality of reporting for platelet transfusion studies. Transfusion. 50:2135-2144. 2010
- Practices associated with ABO‐incompatible platelet transfusions: a BEST Collaborative international survey. Transfusion. 50:1743-1748. 2010
- Transfusion premedication to prevent acute transfusion reactions: a retrospective observational study to assess current practices. Transfusion. 50:1722-1730. 2010
- A pilot study of the possibility and the feasibility of haemoglobin dosing with red blood cells transfusion. Vox Sanguinis. 99:71-76. 2010
- Posttransfusion platelet count increments after ABO‐compatible versus ABO‐incompatible platelet transfusions in noncancer patients: an observational study. Transfusion. 50:1552-1560. 2010
- The randomized controlled trial: in celebration of TRANSFUSION's 50th. Transfusion. 50:1173-1178. 2010
- Duration of red cell storage before transfusion and in-hospital mortality. American Heart Journal. 159:737-743.e1. 2010
- Coombs' crossmatch after negative antibody screening--a retrospective observational study comparing the tube test and the microcolumn technology.. Vox Sanguinis. 98:e269-e275. 2010
- Coombs’ crossmatch after negative antibody screening - a retrospective observational study comparing the tube test and the microcolumn technology. Vox Sanguinis. 98:e269-e275. 2010
- Combination immunosuppressant therapy for patients with chronic refractory immune thrombocytopenic purpura. Blood. 115:29-31. 2010
- Geographical variations in the correlates of blood donor turnout rates: An investigation of Canadian metropolitan areas. International Journal of Health Geographics. 8:56. 2009
- Diagnostic Utility of Platelet Secretion Testing by ATP Release Assays: Results From a Prospective Study of Individuals Referred for Bleeding Disorder Assessments.. Blood. 114:1314-1314. 2009
- Platelet quality measured with dynamic light scattering correlates with transfusion outcome in hematologic malignancies. Transfusion. 49:2276-2284. 2009
- Reviewing manuscripts: tips and responsibilities. Transfusion. 49:2265-2268. 2009
- Measuring and reporting the effect of an intervention: absolute measures. Transfusion. 49:2022-2023. 2009
- Measuring and reporting the effect of an intervention: absolute measures. Transfusion. 49:2022-2023. 2009
- ERRATA. Transfusion. 49:2012-2012. 2009
- Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses (vol 46, pg 1286, 2006). Transfusion. 49:2012-2012. 2009
- Diagnostic utility of light transmission platelet aggregometry: results from a prospective study of individuals referred for bleeding disorder assessments. Journal of Thrombosis and Haemostasis. 7:676-684. 2009
- A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia. Blood. 113:1564-1573. 2009
- CONSORT comes to TRANSFUSION. Transfusion. 49:194-195. 2009
- Clinical and laboratory practices in investigation of suspected transfusion‐transmitted bacterial infection: a survey of Canadian hospitals. Vox Sanguinis. 96:157-159. 2009
- Factors affecting the frequency of red blood cell outdates: an approach to establish benchmarking targets. Transfusion. 49:219-226. 2009
- Measuring and reporting the effect of an intervention: relative measures. Transfusion. 49:9-12. 2009
- Neurodevelopmental Outcome of Extremely Low Birth Weight Infants Randomly Assigned to Restrictive or Liberal Hemoglobin Thresholds for Blood Transfusion. Pediatrics. 123:207-213. 2009
- A policy informing qualitative study to improve the process of blood product recalls and withdrawals. Transfusion. 48:2585-2595. 2008
- Errors in patient specimen collection: application of statistical process control. Transfusion. 48:2143-2151. 2008
- Predictors of clinical outcome in patients with heparin-induced thrombocytopenia treated with direct thrombin inhibition. Blood Coagulation and Fibrinolysis. 19:471-475. 2008
- Comparing the efficacy and safety of apheresis and whole blood–derived platelet transfusions: a systematic review. Transfusion. 48:1447-1458. 2008
- A multicenter pilot‐randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation. Transfusion. 48:81-91. 2008
- An evaluation of methods for determining reference intervals for light transmission platelet aggregation tests on samples with normal or reduced platelet counts. Thrombosis and Haemostasis. 100:01-12. 2008
- New Strategies for the Optimal Use of Platelet Transfusions. Hematology. American Society of Hematology. Education Program. 2008:198-204. 2008
- Understanding the meaning of permanent deferral for blood donors. Transfusion. 48:64-72. 2008
- Designing laboratory‐based research studies: is it time for a change?. Transfusion. 47:2336-2337. 2007
- Gender Differences in Bleeding Problems and Implications for the Assessment of a Bleeding Disorder.. Blood. 110:2148-2148. 2007
- Prevention of bedside errors in transfusion medicine (PROBE‐TM) study: a cluster‐randomized, matched‐paired clinical areas trial of a simple intervention to reduce errors in the pretransfusion bedside check. Transfusion. 47:771-780. 2007
- A revised classification scheme for acute transfusion reactions. Transfusion. 47:621-628. 2007
- Clinical research design and reporting: always room for improvement!. Transfusion. 47:2-3. 2007
- The research question. Transfusion. 47:15-17. 2007
- A review of randomized controlled trials comparing the effectiveness of hand held computers with paper methods for data collection. BMC Medical Informatics and Decision Making. 6:23. 2006
- A study of the agreement between patient self‐assessment and study personnel assessment of bleeding symptoms. Transfusion. 46:1926-1933. 2006
- The risk of bleeding in thrombocytopenic patients with acute myeloid leukemia. Haematologica. 91:1530-1537. 2006
- The risk of bleeding in thrombocytopenic patients with acute myeloid leukemia.. Haematologica. 91:1530-1537. 2006
- Evidence‐based decision making in transfusion medicine. Vox Sanguinis. 91:214-220. 2006
- The premature infants in need of transfusion (pint) study: A randomized, controlled trial of a restrictive (LOW) versus liberal (HIGH) transfusion threshold for extremely low birth weight infants. Journal of Pediatrics. 149:301-307.e3. 2006
- Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses. Transfusion. 46:1286-1291. 2006
- A descriptive analysis of international transfusion practice and bleeding outcomes in patients with acute leukemia. Transfusion. 46:903-911. 2006
- In vivo recovery and survival of apheresis and whole blood‐derived platelets: a paired comparison in healthy volunteers. Transfusion. 46:257-264. 2006
- Assessing the effectiveness of whole blood–derived platelets stored as a pool: a randomized block noninferiority trial. Transfusion. 45:896-903. 2005
- In vitro evaluation of prestorage pooled leukoreduced whole blood–derived platelets stored for up to 7 days. Transfusion. 45:904-910. 2005
- Handheld computers and paper diaries for documenting the use of factor concentrates used in haemophilia home therapy: a qualitative study. Haemophilia. 11:216-226. 2005
- Comparing hand‐held computers and paper diaries for haemophilia home therapy: a randomized trial. Haemophilia. 10:698-704. 2004
- Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation. Cochrane Database of Systematic Reviews. CD004269. 2004
- Hypotensive transfusion reactions can occur with blood products that are leukoreduced before storage. Transfusion. 44:1361-1366. 2004
- Methods for the analysis of bleeding outcomes in randomized trials of PLT transfusion triggers. Transfusion. 44:1135-1142. 2004
- Bleeding risks associated with inheritance of the Quebec platelet disorder. Blood. 104:159-165. 2004
- Treatment of Heparin-Induced Thrombocytopenia. JAMA Internal Medicine. 164:361-361. 2004
- Intravenous (IV) anti‐D and IV immunoglobulin achieve acute platelet increases by different mechanisms: modulation of cytokine and platelet responses to IV anti‐D by FcγRIIa and FcγRIIIa polymorphisms. British Journal of Haematology. 124:511-518. 2004
- Universal leukoreduction and acute transfusion reactions: putting the puzzle together. Transfusion. 44:1-4. 2004
- A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura. Blood. 102:4306-4311. 2003
- Role of the Hct in the treatment of thrombocytopenic patients. Transfusion. 43:1761-1762. 2003
- The above letter was sent to Heddle et al.: Dr Heddle offered the following reply. Transfusion. 43:1763-1763. 2003
- An international study of the performance of sample collection from patients. Vox Sanguinis. 85:40-47. 2003
- Methodologic issues in the use of bleeding as an outcome in transfusion medicine studies. Transfusion. 43:742-752. 2003
- Developing a tracking system for coagulation factor concentrates in southern Ontario. Transfusion. 43:556-562. 2003
- Clinical Outcomes Following Institution of the Canadian Universal Leukoreduction Program for Red Blood Cell Transfusions. Journal of the American Medical Association (JAMA). 289:1941-1941. 2003
- Laboratory diagnosis of immune heparin-induced thrombocytopenia.. Current hematology reports. 2:148-157. 2003
- The causes and treatment of reactions to platelet transfusions. Transfusion. 43:291-292. 2003
- Evidence‐based clinical reporting: a need for improvement. Transfusion. 42:1106-1110. 2002
- Clinical Research Designs: Quantitative Studies. Vox Sanguinis. 83:247-250. 2002
- Platelet transfusions in children: results of a randomized, prospective, crossover trial of plasma removal and a prospective audit of WBC reduction. Transfusion. 42:753-758. 2002
- A randomized controlled trial comparing the frequency of acute reactions to plasma‐removed platelets and prestorage WBC‐reduced platelets. Transfusion. 42:556-566. 2002
- Comparison of post transfusion platelet response following random donor and apheresis platelets. Blood. 96. 2000
- RBC T activation and hemolysis: implications for pediatric transfusion management. Transfusion. 40:801-812. 2000
- Pathophysiology of febrile nonhemolytic transfusion reactions. Current Opinion in Hematology. 6:420-420. 1999
- A randomized controlled trial comparing plasma removal with white cell reduction to prevent reactions to platelets. Transfusion. 39:231-238. 1999
- The Use and Quality Control of Leukocyte‐Depleted Cell Concentrates. Vox Sanguinis. 75:84-85. 1998
- High-Dose Intravenous Immune Globulin and the Response to Splenectomy in Patients with Idiopathic Thrombocytopenic Purpura. New England Journal of Medicine. 337:1087-1089. 1997
- A Canadian hospital-based HIV/hepatitis C look-back notification program.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 157:149-154. 1997
- High-Dose Intravenous Immune Globulin and the Response to Splenectomy in Patients with Idiopathic Thrombocytopenic Purpura. New England Journal of Medicine. 336:1494-1498. 1997
- Cytokines in Platelet Concentrates. Hematology. 2:473-484. 1997
- Post-transfusion alloimmunization.. British Journal of Haematology. 95:573-574. 1996
- Splenectomy Done during Hematologic Remission To Prevent Relapse in Patients with Thrombotic Thrombocytopenic Purpura. ACP journal club. 125:294-294. 1996
- A prospective study to determine the frequency and clinical significance of alloimmunization post‐transfusion. British Journal of Haematology. 91:1000-1005. 1995
- Noninfectious adverse effects of blood transfusion in the neonate.. Transfusion Medicine Reviews. 9:277-287. 1995
- Three examples of Rh haemolytic disease of the newborn with a negative direct antiglobulin test. Transfusion Medicine. 5:113-116. 1995
- Basic statistics for clinicians: 4. Correlation and regression.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 152:497-504. 1995
- Basic statistics for clinicians: 3. Assessing the effects of treatment: measures of association.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 152:351-357. 1995
- The leukodepletion of cellular blood products in the prevention of HLA- alloimmunization and refractoriness to allogeneic platelet transfusions [editorial]. Blood. 85:603-606. 1995
- Basic statistics for clinicians: 2. Interpreting study results: confidence intervals.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 152:169-173. 1995
- A comparison of two solid phase systems for antibody detection. Immunohematology. 11:8-10. 1995
- Basic statistics for clinicians: 1. Hypothesis testing.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 152:27-32. 1995
- Febrile nonhemolytic transfusion reactions to platelets. Current Opinion in Hematology. 2:478-483. 1995
- The use of anti‐D to improve post‐transfusion platelet response: a randomized trial. British Journal of Haematology. 89:163-168. 1995
- Biologic effects of leukocytes present in transfused cellular blood products. Blood. 84:1703-1721. 1994
- The Role of the Plasma from Platelet Concentrates in Transfusion Reactions. New England Journal of Medicine. 331:625-628. 1994
- The role of ABO compatibility in red cell alloimmunization during pregnancy. Transfusion. 34:360-361. 1994
- The contribution of the haematocrit to thrombocytopenic bleeding in experimental animals. British Journal of Haematology. 86:347-350. 1994
- The Efficacy of Leukodepletion to Improve Platelet Transfusion Response: A Critical Appraisal of Clinical Studies. Transfusion Medicine Reviews. 8:15-28. 1994
- A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions. Transfusion. 33:794-797. 1993
- An index of scientific quality for health reports in the lay press. Journal of Clinical Epidemiology. 46:987-1001. 1993
- THE VALUE OF POSTOPERATIVE RED-CELL TRANSFUSIONS IS UNCLEAR - REPLY. Transfusion. 33:623-623. 1993
- The value of postoperative red cell transfusions is unclear. Transfusion. 33:622-623. 1993
- A retrospective study to determine the risk of red cell alloimmunization and transfusion during pregnancy. Transfusion. 33:217-220. 1993
- OMITTING THE ANTIGLOBULIN CROSSMATCH. British Journal of Haematology. 83:521-523. 1993
- On-site continuing education: one big step for small laboratories.. Canadian journal of medical technology. 55:215-219. 1993
- A randomized trial on the efficacy of an autologous blood drainage and transfusion device in patients undergoing elective knee arthroplasty. Transfusion. 32:742-746. 1992
- A prospective study to determine the safety of omitting the antiglobulin crossmatch from pretransfusion testing. British Journal of Haematology. 81:579-584. 1992
- An animal model of allogeneic donor platelet refractoriness: the effect of the time of leukodepletion. Blood. 79:1371-1375. 1992
- Searching the scientific literature.. Canadian journal of medical technology. 53:210-213. 1991
- Acute Paroxysmal Cold Hemoglobinuria. Transfusion Medicine Reviews. 3:219-229. 1989
- Hypergammaglobulinemia can be associated with a positive direct antiglobulin test, a nonreactive eluate, and no evidence of hemolysis. Transfusion. 28:29-33. 1988
- Proffered papers: a mechanism for promoting professionalism?. Canadian journal of medical technology. 49:123-125. 1987
- Anti‐Lu17. Transfusion. 26:306-306. 1986
- Association of renal failure with lewis incompatibility after allogeneic bone marrow transplantation. American Journal of Medicine. 79:143-146. 1985
- HLA-restricted lymphoproliferative responses to MN blood group determinants. Nature. 299:67-69. 1982
- HLA-restricted responses to M and N determinants in the primed lymphocyte test. Human Immunology. 3:325-335. 1981
- Transient Donath‐Landsteiner Haemolytic Anaemia. British Journal of Haematology. 48:425-434. 1981
- GENDER DIFFERENCES IN BLEEDING PROBLEMS AND IMPLICATIONS FOR THE ASSESSMENT OF A BLEEDING DISORDER. Clinical and Investigative Medicine. 31:18-18.